EADO 2022 | Real-life data with sonidegib for locally advanced basal cell carcinoma

Iris Zalaudek, MD, PhD, Dermatology Clinic, University of Trieste, Maggiore Hospital, Trieste, Italy, talks on real-life data with sonidegib for locally advanced basal cell carcinoma including the common side-effects observed. Overall, the findings were promising, indicating sonidegib is well tolerated amongst this patient population. This interview took place at the EADO 2022 congress.